- Home
- BKNG vs BMY Comparison
BKNG vs BMY Comparison
Compare BKNG & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BKNG | BMY |
|---|---|---|
| Founded | 1997 | 1887 |
| Country | United States | United States |
| Employees | N/A | 32500 |
| Industry | Transportation Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.8B | 113.5B |
| IPO Year | 1998 | N/A |
Fundamental Metrics
Financial Performance| Metric | BKNG | BMY |
|---|---|---|
| Price | $163.73 | $56.96 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 32 | 15 |
| Target Price | ★ $228.92 | $61.73 |
| AVG Volume (30 Days) | 6.5M | ★ 9.5M |
| Earning Date | 04-28-2026 | 04-30-2026 |
| Dividend Yield | 0.97% | ★ 4.38% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.36 | N/A |
| Revenue | ★ $26,917,000,000.00 | N/A |
| Revenue This Year | $13.43 | N/A |
| Revenue Next Year | $8.50 | N/A |
| P/E Ratio | $118.11 | ★ $17.26 |
| Revenue Growth | ★ 13.39 | N/A |
| 52 Week Low | $150.14 | $42.52 |
| 52 Week High | $5,837.03 | $62.89 |
Technical Indicators
Market Signals| Indicator | BKNG | BMY |
|---|---|---|
| Relative Strength Index (RSI) | 15.55 | 51.68 |
| Support Level | $150.14 | $56.36 |
| Resistance Level | $193.92 | $60.50 |
| Average True Range (ATR) | 5.06 | 1.41 |
| MACD | 45.02 | 0.05 |
| Stochastic Oscillator | 36.88 | 51.82 |
Price Performance
Historical ComparisonAbout BKNG Booking Holdings Inc.
Booking is the world's largest online travel agency by sales, offering booking and payment services for hotel and alternative accommodation rooms, airlines, rental cars, restaurants, cruises, experiences, and other vacation packages. The company operates several branded travel booking sites, including Booking.com, Agoda, OpenTable, Rentalcars.com, and Kayak. Transaction fees for online bookings account for the bulk of revenue and profits.
About BMY Bristol-Myers Squibb Company
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.